Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Gerhild Fabjani"'
Autor:
Barbara Ziegler, Sabine Zöchbauer-Müller, Gernot Kriegshäuser, Gerhild Fabjani, Adelheid End, Robert Zeillinger
Publikováno v:
International Journal of Molecular Sciences, Vol 12, Iss 12, Pp 8530-8538 (2011)
This study is aimed at evaluating the potential of a biochip assay to sensitively detect KRAS mutation in DNA from non-small cell lung cancer (NSCLC) tissue samples. The assay covers 10 mutations in codons 12 and 13 of the KRAS gene, and is based on
Externí odkaz:
https://doaj.org/article/0d9716bb02964e46bc1a5d05035ab0f2
Autor:
Bernd C. Schmid, Robert Zeillinger, Sepp Leodolter, Toshiyuki Yoneda, Günther A. Rezniczek, Gerhild Fabjani
Publikováno v:
Breast Cancer Research and Treatment. 106:333-342
Cell migration is essential in many diverse processes ranging from embryonic development to wound healing and immune response. Cancer cells have recently been shown to utilize chemoattraction mechanisms mediated by chemokines and their respective rec
Autor:
Eva Schuster, Dan Cacsire Castillo-Tong, Rafał Watrowski, Michael Fischer, Robert Zeillinger, Gerhild Fabjani
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 37(1)
The 15-kDa selenoprotein (Sep15) is a selenocysteine-containing oxidoreductase in the endoplasmic reticulum that participates in disulfide-bond formation and protein folding control. The 3′-untranslated region (3′-UTR) contains two exclusively li
Publikováno v:
Clinical Chemistry. 51:784-787
Ovarian carcinoma is the fifth most common female cancer type and the most common cause of death from gynecologic malignancies in the Western world (1). The three members of the ras gene family, H- ras , K- ras , and N- ras , are among the most commo
Autor:
Rene Wenzl, Friitz Wieser, Johnnes Huber, Christian Schneeberger, Clemens B. Tempfer, Gerhild Fabjani, Michael Sator
Publikováno v:
Journal of the Society for Gynecologic Investigation. 10:32-36
Objective:Interleukin (IL)-6 has been implicated in the etiology of endometriosis. A single nucleotide polymorphism (SNP) at position -174 in the IL-6 gene promoter appears to influence IL-6 transcription rates in vitro and basal IL-6 levels in vivo.
Autor:
Rene Wenzl, Clemens Tempfer, Gerhild Fabjani, Johannes C. Huber, Christian Schneeberger, Fritz Wieser, Michael Sator
Publikováno v:
Journal of the Society for Gynecologic Investigation. 10:32-36
Interleukin (IL)-6 has been implicated in the etiology of endometriosis. A single nucleotide polymorphism (SNP) at position - 174 in the IL-6 gene promoter appears to influence IL-6 transcription rates in vitro and basal IL-6 levels in vivo. We deter
Autor:
Fritz Wieser, Robert Zeillinger, Johannes C. Huber, Rene Wenzl, Clemens Tempfer, Christian Schneeberger, Gerhild Fabjani
Publikováno v:
Journal of the Society for Gynecologic Investigation. 9:313-318
To explore whether having the mutant tumor necrosis factor (TNF)2 (G-308*A) and TNFA-A (G-238*A) alleles in the TNF-alpha gene promotor region is higher in women with endometriosis, we determined the respective genotype and allele frequencies in a re
Autor:
Sepp Leodolter, Gerhild Fabjani, Eva Schuster, Robert Zeillinger, Dan Tong, Paul Speiser, Klaus Czerwenka
Publikováno v:
Breast Cancer Research and Treatment. 72:131-137
A germline TaqI restriction fragment length polymorphism in the intron G of the progesterone receptor (PR) gene designated PROGINS was described to be associated with an increased risk for ovarian carcinoma. It was supposed that the PR isoform A prot
Autor:
Elisabeth Kucera, Michael Minai-Pour, Gerhild Fabjani, Angelika Reiner, Gerhard Sliutz, Sepp Leodolter, Robert Zeillinger, Klaus Czerwenka, Eva Schuster
Publikováno v:
Cancer Letters. 175:205-211
Putative precursors of endometrial cancer such as complex endometrial hyperplasia with atypia have been described to be monoclonal and considered to be genetically related. In order to identify a genetic marker that could serve as a putative predicto
Publikováno v:
BMC Cancer
BMC Cancer, Vol 8, Iss 1, p 13 (2008)
BMC Cancer, Vol 8, Iss 1, p 13 (2008)
Background Many cancer cells produce interleukin-6 (IL-6), a cytokine that plays a role in growth stimulation, metastasis, and angiogenesis of secondary tumours in a variety of malignancies, including colorectal cancer. Effectiveness of IL-6 in this